G. Mlinaric-galinovic, A. Falsey, and E. Walsh, Respiratory syncytial virus infection in the elderly, European Journal of Clinical Microbiology & Infectious Diseases, vol.125, issue.10, pp.777-81, 1996.
DOI : 10.1093/infdis/165.6.987

A. Falsey, R. Mccann, and W. Hall, The ???Common Cold??? in Frail Older Persons: Impact of Rhinovirus and Coronavirus in a Senior Daycare Center, Journal of the American Geriatrics Society, vol.44, issue.6, pp.706-717, 1997.
DOI : 10.1111/j.1532-5415.1996.tb01859.x

A. Falsey, E. Walsh, and F. Hayden, Rhinovirus and Coronavirus Infection???Associated Hospitalizations among Older Adults, The Journal of Infectious Diseases, vol.185, issue.9, pp.1338-1379, 2002.
DOI : 10.1086/339881
URL : https://academic.oup.com/jid/article-pdf/185/9/1338/18006519/185-9-1338.pdf

L. Han, J. Alexander, and L. Anderson, Respiratory Syncytial Virus Pneumonia among the Elderly: An Assessment of Disease Burden, The Journal of Infectious Diseases, vol.179, issue.1, pp.25-30, 1999.
DOI : 10.1086/314567

G. Gorse, O. Connor, T. Hall, S. Vitale, J. Nichol et al., Human Coronavirus and Acute Respiratory Illness in Older Adults with Chronic Obstructive Pulmonary Disease, The Journal of Infectious Diseases, vol.199, issue.6, pp.847-57, 2009.
DOI : 10.1086/597122

C. Wendt and M. Hertz, Respiratory syncytial virus and parainfluenza virus infections in the immunocompromised host, Semin Respir Infect, vol.10, pp.224-255, 1995.

V. Liu, G. Dhillon, and D. Weill, A multi-drug regimen for respiratory syncytial virus and parainfluenza virus infections in adult lung and heart-lung transplant recipients, Transplant Infectious Disease, vol.12, issue.1, pp.38-44, 2010.
DOI : 10.1111/j.1399-3062.2009.00453.x

C. Godet, L. Goff, J. Beby-defaux, and A. , Human metapneumovirus pneumonia in patients with hematological malignancies, Journal of Clinical Virology, vol.61, issue.4, pp.593-599, 2014.
DOI : 10.1016/j.jcv.2014.08.019

M. Lee, R. Walker, and P. Mendelman, Medical Burden of Respiratory Syncytial Virus and Parainfluenza Virus Type 3 Infection Among US Children: Implications for Design of Vaccine Trials, Human Vaccines, vol.1, issue.1, pp.6-11, 2005.
DOI : 10.4161/hv.1.1.1424

A. Falsey, Human Metapneumovirus Infection in Adults, The Pediatric Infectious Disease Journal, vol.27, issue.Supplement, pp.80-83, 2008.
DOI : 10.1097/INF.0b013e3181684dac
URL : http://pdfs.journals.lww.com/pidj/2008/10001/Human_Metapneumovirus_Infection_in_Adults.9.pdf?token=method|ExpireAbsolute;source|Journals;ttl|1503149717718;payload|mY8D3u1TCCsNvP5E421JYK6N6XICDamxByyYpaNzk7FKjTaa1Yz22MivkHZqjGP4kdS2v0J76WGAnHACH69s21Csk0OpQi3YbjEMdSoz2UhVybFqQxA7lKwSUlA502zQZr96TQRwhVlocEp/sJ586aVbcBFlltKNKo+tbuMfL73hiPqJliudqs17cHeLcLbV/CqjlP3IO0jGHlHQtJWcICDdAyGJMnpi6RlbEJaRheGeh5z5uvqz3FLHgPKVXJzdvEFnVrrJ5mORgYGWx8uf3EHHm+yV6aVbDHz4jbzC0NA=;hash|OyuIx/rC1G/u7O3Zi5cqYw==

J. Ramirez, RSV infection in the adult population, Manag Care, vol.17, issue.11, pp.13-18, 2008.

M. Villaran, J. García, and J. Gomez, Human parainfluenza virus in patients with influenza-like illness from Central and South America during 2006-2010, Influenza and Other Respiratory Viruses, vol.31, issue.Suppl 1, pp.217-244, 2014.
DOI : 10.1097/INF.0b013e31823386f1

Y. Wang, J. W. Chen, Z. Yan, Y. Shao, X. Xu et al., Comparison of severe pneumonia caused by Human metapneumovirus and respiratory syncytial virus in hospitalized children, Indian J Pathol Microbiol, vol.57, pp.413-420, 2014.

K. Widmer, M. Griffin, Y. Zhu, J. Williams, and H. Talbot, Respiratory syncytial virus- and human metapneumovirus-associated emergency department and hospital burden in adults, Influenza and Other Respiratory Viruses, vol.31, issue.10 Suppl, pp.347-52, 2014.
DOI : 10.1086/653202

I. Stefanska, M. Romanowska, S. Donevski, D. Gawryluk, and L. Brydak, Co-Infections with Influenza and Other Respiratory Viruses, Adv Exp Med Biol, vol.756, pp.291-301, 2013.
DOI : 10.1007/978-94-007-4549-0_36

S. Kouni, P. Karakitsos, and A. Chranioti, Evaluation of viral co-infections in hospitalized and non-hospitalized children with respiratory infections using microarrays, Clinical Microbiology and Infection, vol.19, issue.8, pp.772-77, 2013.
DOI : 10.1111/1469-0691.12015

E. Goka, P. Vallely, and K. Mutton, Influenza A viruses dual and multiple infections with other respiratory viruses and risk of hospitalisation and mortality, Influenza and Other Respiratory Viruses, vol.16, issue.1, pp.1079-1087, 2013.
DOI : 10.1002/jmv.20246

S. Asner, M. Science, and D. Tran, Clinical Disease Severity of Respiratory Viral Co-Infection versus Single Viral Infection: A Systematic Review and Meta-Analysis, PLoS ONE, vol.4, issue.6, p.99392, 2014.
DOI : 10.1371/journal.pone.0099392.s002

E. Goka, P. Vallely, and K. Mutton, Single, dual and multiple respiratory virus infections and risk of hospitalization and mortality, Epidemiology and Infection, vol.129, issue.01, pp.37-47, 2015.
DOI : 10.1371/journal.pone.0009025

S. Asner, W. Rose, and A. Petrich, Is virus coinfection a predictor of severity in children with viral respiratory infections?, Clinical Microbiology and Infection, vol.21, issue.3, pp.264-265, 2015.
DOI : 10.1016/j.cmi.2014.08.024

G. Rakes, E. Arruda, and J. Ingram, Rhinovirus and Respiratory Syncytial Virus in Wheezing Children Requiring Emergency Care, American Journal of Respiratory and Critical Care Medicine, vol.89, issue.3, pp.785-90, 1999.
DOI : 10.1093/intimm/4.4.493

T. Jartti, P. Lehtinen, and T. Vanto, Evaluation of the Efficacy of Prednisolone in Early Wheezing Induced by Rhinovirus or Respiratory Syncytial Virus, The Pediatric Infectious Disease Journal, vol.25, issue.6, pp.482-490, 2006.
DOI : 10.1097/01.inf.0000215226.69696.0c

R. Emuzyte, R. Firantiene, R. Petraityte, and K. Sasnauskas, Human rhinoviruses, allergy, and asthma: a clinical approach, Medicina (Kaunas), vol.45, pp.839-886, 2009.

P. Sly, M. Kusel, and P. Holt, Do early-life viral infections cause asthma?, Journal of Allergy and Clinical Immunology, vol.125, issue.6, pp.1202-1207, 2010.
DOI : 10.1016/j.jaci.2010.01.024

T. Jartti and M. Korppi, Rhinovirus-induced bronchiolitis and asthma development, Pediatric Allergy and Immunology, vol.64, issue.4, pp.350-355, 2011.
DOI : 10.1111/j.1398-9995.2009.02022.x

M. Ruotsalainen, M. Hyvärinen, E. Piippo-savolainen, and M. Korppi, Adolescent asthma after rhinovirus and respiratory syncytial virus bronchiolitis, Pediatric Pulmonology, vol.185, issue.7, pp.633-642, 2013.
DOI : 10.1164/rccm.201104-0660OC

A. Agrawal, T. Roy, S. Ghosh, and M. Chawla-sarkar, Genetic variability of attachment (G) and Fusion (F) protein genes of human metapneumovirus strains circulating during 2006-2009 in Kolkata, Eastern India, Virology Journal, vol.8, issue.1, p.67, 2006.
DOI : 10.1186/1743-422X-8-67

J. Papenburg, J. Carbonneau, and S. Isabel, Genetic diversity and molecular evolution of the major human metapneumovirus surface glycoproteins over a decade, Journal of Clinical Virology, vol.58, issue.3, pp.541-548, 2013.
DOI : 10.1016/j.jcv.2013.08.029

D. Bernstein, E. Malkin, and N. Abughali, Phase 1 Study of the Safety and Immunogenicity of a Live, Attenuated Respiratory Syncytial Virus and Parainfluenza Virus Type 3 Vaccine in Seronegative Children, The Pediatric Infectious Disease Journal, vol.31, issue.2, pp.109-123, 2012.
DOI : 10.1097/INF.0b013e31823386f1

J. Englund, R. Karron, and C. Cunningham, Safety and infectivity of two doses of live-attenuated recombinant cold-passaged human parainfluenza type 3 virus vaccine rHPIV3cp45 in HPIV3-seronegative young children, Vaccine, vol.31, issue.48, pp.5706-5718, 2013.
DOI : 10.1016/j.vaccine.2013.09.046

C. Nelson, R. Tang, and E. Stillman, Genetic stability of RSV-F expression and the restricted growth phenotype of a live attenuated PIV3 vectored RSV vaccine candidate (MEDI-534) following restrictive growth in human lung cells, Vaccine, vol.31, issue.36, pp.3756-62, 2013.
DOI : 10.1016/j.vaccine.2013.04.015

C. Li, X. Zhou, and Y. Zhong, A Recombinant G Protein Plus Cyclosporine A???Based Respiratory Syncytial Virus Vaccine Elicits Humoral and Regulatory T Cell Responses against Infection without Vaccine-Enhanced Disease, The Journal of Immunology, vol.77, issue.11, pp.1721-1752, 2016.
DOI : 10.1128/JVI.77.11.6580-6584.2003

K. Neuzil, ABSTRACT, Clinical and Vaccine Immunology, vol.23, issue.3, pp.186-194, 2016.
DOI : 10.1128/CVI.00037-16

G. Campanini, A. Piralla, and F. Rovida, First case in Italy of acquired resistance to oseltamivir in an immunocompromised patient with influenza A/H1N1v infection, Journal of Clinical Virology, vol.48, issue.3, pp.220-222, 2010.
DOI : 10.1016/j.jcv.2010.03.027

M. Ujike, M. Ejima, and A. Anraku, Monitoring and Characterization of Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus, Japan, 2009???2010, Emerging Infectious Diseases, vol.17, issue.3, pp.470-479, 2009.
DOI : 10.3201/eid1703.101188

M. Suhaila, J. Tang, and H. Lee, Mixtures of Oseltamivir-sensitive and -resistant Pandemic Influenza A/H1N1/2009 Viruses in Immunocompromised Hospitalized Children, The Pediatric Infectious Disease Journal, vol.30, issue.7, pp.625-632, 2011.
DOI : 10.1097/INF.0b013e31820929ab

A. Hurt, T. Chotpitayasunondh, and N. Cox, Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives, The Lancet Infectious Diseases, vol.12, issue.3, pp.240-248, 2012.
DOI : 10.1016/S1473-3099(11)70318-8

O. Adams, L. Bonzel, A. Kovacevic, E. Mayatepek, T. Hoehn et al., Palivizumab???Resistant Human Respiratory Syncytial Virus Infection in Infancy, Clinical Infectious Diseases, vol.51, issue.2, pp.185-193, 2010.
DOI : 10.1086/653534

Q. Zhu, J. Mcauliffe, and N. Patel, Analysis of Respiratory Syncytial Virus Preclinical and Clinical Variants Resistant to Neutralization by Monoclonal Antibodies Palivizumab and/or Motavizumab, The Journal of Infectious Diseases, vol.78, issue.Pt 3, pp.674-82, 2011.
DOI : 10.1128/JVI.78.18.9837-9841.2004

Q. Xia, L. Zhou, and C. Peng, Detection of respiratory syncytial virus fusion protein variants between 2009 and 2012 in China, Archives of Virology, vol.276, issue.5, pp.1089-98, 2014.
DOI : 10.1074/jbc.M102633200

J. Bates, C. Keefer, J. Slaughter, D. Kulp, W. Schief et al., Escape from neutralization by the respiratory syncytial virus-specific neutralizing monoclonal antibody palivizumab is driven by changes in on-rate of binding to the fusion protein, Virology, vol.454, issue.455, pp.454-55139, 2014.
DOI : 10.1016/j.virol.2014.02.010

D. Oliveira, M. Iwane, and M. Prill, Molecular characterization of respiratory syncytial viruses infecting children reported to have received palivizumab immunoprophylaxis, Journal of Clinical Virology, vol.65, pp.26-31, 2015.
DOI : 10.1016/j.jcv.2015.01.016

D. Corti, S. Bianchi, and F. Vanzetta, Cross-neutralization of four paramyxoviruses by a human monoclonal antibody, Nature, vol.1, issue.7467, pp.439-482, 2013.
DOI : 10.1007/BF01721323

A. Kistler, D. Webster, and S. Rouskin, Genome-wide diversity and selective pressure in the human rhinovirus, Virology Journal, vol.4, issue.1, p.40, 2007.
DOI : 10.1186/1743-422X-4-40

N. Lewis-rogers, M. Bendall, and K. Crandall, Phylogenetic Relationships and Molecular Adaptation Dynamics of Human Rhinoviruses, Molecular Biology and Evolution, vol.22, issue.4, pp.969-81, 2009.
DOI : 10.1093/molbev/msi097

V. Waman, P. Kolekar, M. Kale, and U. Kulkarni-kale, Population Structure and Evolution of Rhinoviruses, PLoS ONE, vol.80, issue.22, p.88981, 2014.
DOI : 10.1371/journal.pone.0088981.s010

A. Zumla, J. Chan, E. Azhar, D. Hui, and K. Yuen, Coronaviruses ??? drug discovery and therapeutic options, Nature Reviews Drug Discovery, vol.351, issue.5, pp.327-374, 2016.
DOI : 10.1126/science.aad1283

B. Bosch, J. Rossen, and W. Bartelink, Coronavirus Escape from Heptad Repeat 2 (HR2)-Derived Peptide Entry Inhibition as a Result of Mutations in the HR1 Domain of the Spike Fusion Protein, Journal of Virology, vol.82, issue.5, pp.2580-2585, 2008.
DOI : 10.1128/JVI.02287-07

. Authors, Affiliations 1. Asha Mary Abraham, Christian Medical College

A. Baraket, Centre National de référence de la grippe

M. Caniza and S. Jude, Children's Research Hospital

K. Paul and . Chan, The Chinese University of Hong Kong SAR

C. Cohen, National Institute for Communicable Diseases (NICD)

A. Corriveau, Government of the Northwest Territories

J. Benjamin and . Cowling, The University of Hong Kong

H. Jalal, Addenbrookes Hospital

M. Krajden, British Columbia Centre for Disease Prevention and Control

T. Tommy and . Lam, The University of Hong Kong

T. Saiyed, Centre for Cellular and Molecular Platforms

A. Shet and . St, John's Medical College Hospital

S. Tozer, Centre for Children's Health Research

F. Treurnicht, National Institute for Communicable Diseases